APPLICATION
ANDA208340
TYPE
ANDA
ORIGINAL APPROVAL
2017-04-13
LATEST ACTION
2026-03-17
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
PIROXICAMDiscontinued
PIROXICAM 10MG · CAPSULE · ORAL
PIROXICAMDiscontinued
PIROXICAM 20MG · CAPSULE · ORAL
Approval history
2026-03-17Labeling · Supplement 12 · standardAP
2023-02-21Labeling · Supplement 10 · standardAP
2023-02-21Labeling · Supplement 8 · standardAP
2019-10-17Labeling · Supplement 3 · standardAP
2017-04-13UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.